These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 36979408)

  • 21. Epipharyngeal Abrasive Therapy Down-regulates the Expression of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2.
    Nishi K; Yoshimoto S; Nishi S; Tsunoda T; Ohno J; Yoshimura M; Hiromatsu K; Yamano T
    In Vivo; 2022; 36(1):371-374. PubMed ID: 34972736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.
    Menon R; Otto EA; Sealfon R; Nair V; Wong AK; Theesfeld CL; Chen X; Wang Y; Boppana AS; Luo J; Yang Y; Kasson PM; Schaub JA; Berthier CC; Eddy S; Lienczewski CC; Godfrey B; Dagenais SL; Sohaney R; Hartman J; Fermin D; Subramanian L; Looker HC; Harder JL; Mariani LH; Hodgin JB; Sexton JZ; Wobus CE; Naik AS; Nelson RG; Troyanskaya OG; Kretzler M
    Kidney Int; 2020 Dec; 98(6):1502-1518. PubMed ID: 33038424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection.
    Gao X; Zhang S; Gou J; Wen Y; Fan L; Zhou J; Zhou G; Xu G; Zhang Z
    J Infect; 2022 Oct; 85(4):418-427. PubMed ID: 35793758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
    Kimura H; Francisco D; Conway M; Martinez FD; Vercelli D; Polverino F; Billheimer D; Kraft M
    J Allergy Clin Immunol; 2020 Jul; 146(1):80-88.e8. PubMed ID: 32422146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
    Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
    Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.
    Ma D; Chen CB; Jhanji V; Xu C; Yuan XL; Liang JJ; Huang Y; Cen LP; Ng TK
    Eye (Lond); 2020 Jul; 34(7):1212-1219. PubMed ID: 32382146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
    Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise-induced myokines downregulates the ACE2 level in bronchial epithelial cells: Implications for SARS-CoV-2 prevention.
    Bhardwaj V; Dela Cruz M; Subramanyam D; Kumar R; Markan S; Parker B; Roy HK
    PLoS One; 2022; 17(7):e0271303. PubMed ID: 35857747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery.
    Lores E; Wysocki J; Batlle D
    Clin Sci (Lond); 2020 Nov; 134(21):2791-2805. PubMed ID: 33135725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE2 and TMPRSS2 immunolocalization and oral manifestations of COVID-19.
    Park GC; Bang SY; Lee HW; Choi KU; Kim JM; Shin SC; Cheon YI; Sung ES; Lee M; Lee JC; Kim HS; Lee BJ
    Oral Dis; 2022 Nov; 28 Suppl 2():2456-2464. PubMed ID: 35000261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2.
    Rangu R; Wander PL; Barrow BM; Zraika S
    J Mol Endocrinol; 2022 Jun; 69(2):R63-R79. PubMed ID: 35521990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of ACE2 on the susceptibility and vulnerability to COVID-19.
    Pringle KG; Philp LK
    J Endocrinol; 2023 Sep; 258(3):. PubMed ID: 37439513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgens, the kidney, and COVID-19: an opportunity for translational research.
    Yanes Cardozo LL; Rezq S; Pruett JE; Romero DG
    Am J Physiol Renal Physiol; 2021 Feb; 320(2):F243-F248. PubMed ID: 33464168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated ethanol exposure and withdrawal alters angiotensin-converting enzyme 2 expression in discrete brain regions: Implications for SARS-CoV-2 neuroinvasion.
    Balasubramanian N; James TD; Selvakumar GP; Reinhardt J; Marcinkiewcz CA
    Alcohol Clin Exp Res (Hoboken); 2023 Feb; 47(2):219-239. PubMed ID: 36529893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated FiO
    Myti D; Gunjak M; Casado F; Khaghani Raziabad S; Nardiello C; Vadász I; Herold S; Pryhuber G; Seeger W; Morty RE
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L670-L674. PubMed ID: 32878480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies.
    Ragia G; Manolopoulos VG
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1623-1630. PubMed ID: 32696234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on the potential of Sanghuangporus sanghuang and its components as COVID-19 spike protein receptor binding domain inhibitors.
    Chien LH; Deng JS; Jiang WP; Chen CC; Chou YN; Lin JG; Huang GJ
    Biomed Pharmacother; 2022 Sep; 153():113434. PubMed ID: 36076488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.